Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Significance: This report reveals the influence of sialylation on the activation of epidermal growth factor receptor (EGFR) and sensitivity to tyrosine kinase inhibitors (TKIs) against EGFR phosphorylation. By utilizing biochemical approaches, we demonstrated that EGFR sialylation suppresses EGFR phosphorylation by inhibiting EGF binding and EGFR dimerization. In the TKI-resistant lung cancer cell line with L858R/T790M mutations on EGFR, the levels of phosphorylation at Y1068, Y1086, and Y1173 are upregulated, and sialylation can partially suppress the phosphorylation of EGFR at these sites and enhance EGFR sensitivity to TKI. These findings suggest that sialylation has an important role in tumorigenesis and sensitivity to TKIs by modulating EGFR phosphorylation and the associated signaling network and provide insights for therapeutic intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a similar vein, both sialylation and fucosylation modulate epidermal growth factor receptor-mediated intracellular signaling (528 -530).”
From Biological roles of glycans (2017) · cites this paper as [530]
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020073 · Cited by 3,527
PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
Hornbeck, P. V., Zhang, B., Murray, B., Kornhauser, J. M., Latham, V., & Skrzypek, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1267 · Cited by 3,411
Epidermal growth factor receptor mutations in lung cancer
Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Yun, C.-H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709662105 · Cited by 2,118
EGF–ERBB signalling: towards the systems level
Citri, A., & Yarden, Y. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1962 · Cited by 2,004
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227
Yun, C.-H., Boggon, T. J., Li, Y., Woo, M. S., Greulich, H., Meyerson, M., & Eck, M. J. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.017 · Cited by 1,192
Research works printed but not linked: 1
- 10.1128/mcb.14.8.5192-5201.1994 · doi:10.1128/mcb.14.8.5192-5201.1994 · Paper page
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Mereiter, S., Balmaña, M., Campos, D., Gomes, J., & Reis, C. A. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.06.006 · Cited by 565
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments
Shivatare, S. S., Shivatare, V. S., & Wong, C.-H. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c01032 · Cited by 257
Self-citationWu, J., Chen, S., Liu, H., Zhang, Z., Ni, Z., Chen, J., Yang, Z., Nie, Y., & Fan, D. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0935-8 · Cited by 223
Aptamer Therapeutics in Cancer: Current and Future
Morita, Y., Leslie, M., Kameyama, H., Volk, D., & Tanaka, T. (2018) · Cancers · doi:10.3390/cancers10030080 · Cited by 217
Biological Functions and Analytical Strategies of Sialic Acids in Tumor
Zhou, X., Yang, G., & Guan, F. (2020) · Cells · doi:10.3390/cells9020273 · Cited by 182
Wu, X., Zhao, J., Ruan, Y., Sun, L., Xu, C., & Jiang, H. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-1101-0 · Cited by 170
Siglec receptors as new immune checkpoints in cancer
Stanczak, M. A., & Laubli, H. P. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101112 · Cited by 143
Britain, C. M., Holdbrooks, A. T., Anderson, J. C., Willey, C. D., & Bellis, S. L. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0385-0 · Cited by 124
Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling
Ferreira, I. G., Pucci, M., Venturi, G., Malagolini, N., Chiricolo, M., & Dall’Olio, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020580 · Cited by 136
Aberrant Sialylation in Cancer: Therapeutic Opportunities
Munkley, J. (2022) · Cancers · doi:10.3390/cancers14174248 · Cited by 125
Martin-Fernandez, M. L., Clarke, D. T., Roberts, S. K., Zanetti-Domingues, L. C., & Gervasio, F. L. (2019) · Cells · doi:10.3390/cells8040316 · Cited by 100
E-cadherin-mediated force transduction signals regulate global cell mechanics
Muhamed, I., Wu, J., Sehgal, P., Kong, X., Tajik, A., Wang, N., & Leckband, D. E. (2016) · Journal of Cell Science · doi:10.1242/jcs.185447 · Cited by 97
“At concentrations that block EGFR transphosphorylation (Yen et al., 2015), Gefitinib abrogated MCF7 cell stiffening, relative to vehicle controls (DMSO) or untreated cells (Fig.”
BackgroundA data-independent acquisition-based global phosphoproteomics system enables deep profiling
Kitata, R. B., Choong, W.-K., Tsai, C.-F., Lin, P.-Y., Chen, B.-S., Chang, Y.-C., Nesvizhskii, A. I., Sung, T.-Y., & Chen, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-22759-z · Cited by 103
Self-citationThe promise of protein glycosylation for personalised medicine
Almeida, A., & Kolarich, D. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.03.012 · Cited by 101
Chandler, K. B., Leon, D. R., Kuang, J., Meyer, R., Rahimi, N., & Costello, C. E. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008643 · Cited by 86
Chandler, K. B., & Costello, C. E. (2016) · Electrophoresis · doi:10.1002/elps.201500552 · Cited by 89
Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis
Haxho, F., Neufeld, R. J., & Szewczuk, M. R. (2016) · Oncotarget · doi:10.18632/oncotarget.8396 · Cited by 80
Drug-biomarker co-development in oncology – 20 years and counting
Twomey, J. D., Brahme, N. N., & Zhang, B. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.02.002 · Cited by 83
Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells
Jiang, Q., Yang, M., Qu, Z., Zhou, J., & Zhang, Q. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1956-0 · Cited by 76
Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation
Micheau, O. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030715 · Cited by 76
Britain, C. M., Bhalerao, N., Silva, A. D., Chakraborty, A., Buchsbaum, D. J., Crowley, M. R., Crossman, D. K., Edwards, Y. J. K., & Bellis, S. L. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014126 · Cited by 62
Wen, K., Sung, P., Hsieh, S.-L. E., Chou, Y., Lee, O. K., Wu, C., & Wang, P. (2017) · Oncotarget · doi:10.18632/oncotarget.15994 · Cited by 58
N-glycans of growth factor receptors: their role in receptor function and disease implications
Takahashi, M., Hasegawa, Y., Gao, C., Kuroki, Y., & Taniguchi, N. (2016) · Clinical Science · doi:10.1042/cs20160273 · Cited by 58
Galectins as modulators of receptor tyrosine kinases signaling in health and disease
Porębska, N., Poźniak, M., Matynia, A., Żukowska, D., Zakrzewska, M., Otlewski, J., & Opaliński, Ł. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.03.004 · Cited by 58
Role of Glycans on Key Cell Surface Receptors That Regulate Cell Proliferation and Cell Death
Gao, Y. H., Luan, X., Melamed, J., & Brockhausen, I. (2021) · Cells · doi:10.3390/cells10051252 · Cited by 60
Lo, H.-J., Krasnova, L. B., Dey, S., Cheng, T., Liu, H., Tsai, T.-I., Wu, K., Wu, C., & Wong, C. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b01991 · Cited by 52
Self-citationNitrosative Stress and Human Disease: Therapeutic Potential of Denitrosylation
Yoon, S., Eom, G. H., & Kang, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189794 · Cited by 56
Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics
Ankenbauer, K. E., Rao, T. C., Mattheyses, A. L., & Bellis, S. L. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105217 · Cited by 50
1,2,4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLC
Dokla, E. M. E., Fang, C., Abouzid, K. A. M., & Chen, C. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111607 · Cited by 49
N-glycosylation stabilizes MerTK and promotes hepatocellular carcinoma tumor growth
Liu, Y., Lan, L., Li, Y., Lu, J. N., He, L., Deng, Y. J., Fei, M., Lu, J., Shangguan, F., Lu, J.-P., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102366 · Cited by 50
Self-citationGenetics of glycosylation in mammalian development and disease
Stanley, P. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00725-x · Cited by 54
Influenza Virus: A Master Tactician in Innate Immune Evasion and Novel Therapeutic Interventions
Hsu, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00743 · Cited by 47
Glover, M. S., Yu, Q., Chen, Z., Shi, X., Kent, K. C., & Li, L. (2017) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2017.09.002 · Cited by 42
Shukla, H. D. (2017) · Proteomes · doi:10.3390/proteomes5040028 · Cited by 43
Liu, N., Zhu, M., Linhai, Y., Song, Y., Gui, X., Tan, G., Li, J., Liu, Y., Deng, Z., Chen, X., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6680 · Cited by 42
Self-citationChen, Y., Yen, T.-C., Lin, Y.-H., Chen, Y.-L., Khoo, K., & Chen, Y. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03224 · Cited by 41
Self-citationThe blood-borne sialyltransferase ST6Gal-1 is a negative systemic regulator of granulopoiesis
Dougher, C. W. L., Buffone, A., Nemeth, M. J., Nasirikenari, M., Irons, E. E., Bogner, P. N., & Lau, J. T. Y. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1216-538rr · Cited by 40
Wang, Y., Zhang, L., He, Z., Deng, J., Zhang, Z., Liu, L., Ye, W., & Liu, S. (2020) · PubMed · Cited by 48
Self-citationAberrant protein glycosylation in cancer: implications in targeted therapy
Rodrigues, J. G., Duarte, H. O., Reis, C. A., & Gomes, J. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200763 · Cited by 40
Mathew, M. P., Tan, E., Saeui, C. T., Bovonratwet, P., Sklar, S., Bhattacharya, R., & Yarema, K. J. (2016) · Oncotarget · doi:10.18632/oncotarget.11582 · Cited by 35
Advances in the relationship between glycosyltransferases and multidrug resistance in cancer
Wu, Y., Chen, X., Wang, S., & Wang, S. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.05.015 · Cited by 35
Adolescent meal patterns: grazing habits in the west of Scotland.
Anderson, A. S., MacIntyre, S., & West, P. (1993) · PubMed · Cited by 43
Waniwan, J. T., Chen, Y., Capangpangan, R. Y., Weng, S., & Chen, Y. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00433 · Cited by 36
Self-citationMahalapbutr, P., Wonganan, P., Chavasiri, W., & Rungrotmongkol, T. (2019) · Cancers · doi:10.3390/cancers11040437 · Cited by 34
Role of glycosyltransferases in carcinogenesis; growth factor signaling and EMT/MET programs
Takahashi, M., Hasegawa, Y., Maeda, K., Kitano, M., & Taniguchi, N. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10041-3 · Cited by 35
Modified serpinA1 as risk marker for Parkinson’s disease dementia: Analysis of baseline data
Halbgebauer, S., Nagl, M., Klafki, H., Haußmann, U., Steinacker, P., Oeckl, P., Kassubek, J., Pinkhardt, E. H., Ludolph, A. C., Soininen, H. S., et al. (2016) · Scientific Reports · doi:10.1038/srep26145 · Cited by 36
Xie, Y., Xie, J., Huang, G., Zhang, J., Song, C., Luo, Y., Tang, H., Tang, Y., Xiao, X., Zhang, C., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217734 · Cited by 36
Han, C., Chen, X., Lan, A., Hsu, Y., Wu, P., Hung, P., Hung, C., & Pan, S. (2021) · Cancer Science · doi:10.1111/cas.14872 · Cited by 36
Chang, X., Obianwuna, U. E., Wang, J., Zhang, H., Qi, G., Qiu, K., & Wu, S. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123855 · Cited by 34
Zhu, H., & Gao, F. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.21637 · Cited by 36
Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types
Venturi, G., Gomes Ferreira, I., Pucci, M., Ferracin, M., Malagolini, N., Chiricolo, M., & Dall’Olio, F. (2019) · Glycobiology · doi:10.1093/glycob/cwz053 · Cited by 32
Sialylation in the gut: From mucosal protection to disease pathogenesis
Ma, X., Li, M., Wang, X., Qi, G., Wei, L., & Zhang, D. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122471 · Cited by 34
Gong, A., Zhao, X., Pan, Y., Qi, Y., Li, S., Huang, Y., Guo, Y., Qi, X., Zheng, W., & Jia, L. (2020) · Journal of Cell Science · doi:10.1242/jcs.244020 · Cited by 31
Xie, Y., Chen, S., Li, Q., Sheng, Y., Alvarez, M. R., Reyes, J. M., Xu, G., Solakyildirim, K., & Lebrilla, C. B. (2021) · Chemical Science · doi:10.1039/d1sc00814e · Cited by 33
Lee, H., Meng, M., Liu, Y., Su, T., & Kwan, H. Y. (2021) · Oncology Letters · doi:10.3892/ol.2021.12907 · Cited by 31
Self-citationDifferential expression of ST6GAL1 in the tumor progression of colorectal cancer
Zhang, S., Lu, J., Xu, Z., Zou, X., Xue Long, S. U. N., Xu, Y., Shan, A., Lu, J., Yan, X., Cui, Y., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.167 · Cited by 30
Role of IGF-1R in ameliorating apoptosis of GNE deficient cells
Singh, R., Chaudhary, P., & Arya, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-25510-9 · Cited by 29
Balmaña, M., Diniz, F., Feijão, T., Barrias, C. C., Mereiter, S., & Reis, C. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030722 · Cited by 27
Sialic Acid Metabolic Engineering of Breast Cancer Cells Interferes with Adhesion and Migration
Nagasundaram, M., Horstkorte, R., & Gnanapragassam, V. S. (2020) · Molecules · doi:10.3390/molecules25112632 · Cited by 27
CSF SerpinA1 in Creutzfeldt–Jakob disease and frontotemporal lobar degeneration
Abu‐Rumeileh, S., Halbgebauer, S., Steinacker, P., Anderl‐Straub, S., Polischi, B., Ludolph, A. C., Capellari, S., Parchi, P., & Otto, M. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50980 · Cited by 25
Wang, X., Zhang, Y., Lin, H., Liu, Y., Tan, Y., Lin, J., Gao, F., & Lin, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.107 · Cited by 25
Self-citationN-Glycosylation in progression of skin cancer
Tang, L. Y., Chen, X., Zhang, X., Guo, Y., Su, J., Zhang, J., Chen, X., & Chen, X. (2019) · Medical Oncology · doi:10.1007/s12032-019-1270-4 · Cited by 26
Lee, D.-H., Kang, S.-H., Choi, D., Ko, M., Choi, E., Ahn, H., Min, H., Oh, S. J., Lee, M. S., Park, Y., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.006 · Cited by 26
Exploring human glycosylation for better therapies
Krasnova, L. B., & Wong, C. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.05.003 · Cited by 25
Self-citationWu, P., Lin, M., Hsiao, J., Lin, P.-Y., Pan, S., & Chen, Y. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100624 · Cited by 23
Self-citationTa, H. D. K., Xuan, D. T. M., Tang, W., Anuraga, G., Ni, Y.-C., Pan, S.-R., Wu, Y.-F., Fitriani, F., Hermanto, E. M. P., Athoillah, M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9121804 · Cited by 23
Jastrząb, P., Narejko, K., Car, H., & Wielgat, P. (2023) · Cancers · doi:10.3390/cancers15205103 · Cited by 23
Zhou, L., Zhang, S., Zou, X., Lu, J., Yang, X., Xu, Z., Shan, A., Jia, W., Liu, F., Yan, X., et al. (2019) · Cancer Management and Research · doi:10.2147/cmar.s208631 · Cited by 21
Insights on ErbB glycosylation – contributions to precision oncology
Duarte, H. O., Reis, C. A., & Gomes, J. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.02.003 · Cited by 21
Li, J., Long, Y., Sun, J., Wu, J., He, X. H., Wang, S., Wang, X., Miao, X., Huang, R., & Yan, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.931132 · Cited by 20
Kim, S., Park, H., Kim, K., Kim, J., Sung, J. H., Nam, M., Lee, J. H., Jung, E. H., Suh, K. J., Lee, J. Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03197-9 · Cited by 20
Girych, M., Kulig, W., Enkavi, G., & Vattulainen, I. (2023) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041419 · Cited by 18
Halamish, H. M., Zlotver, I., & Sosnik, A. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.07.027 · Cited by 17
HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis
Wu, S., Lin, C., Shih, H.-P., Ko, C., Lin, H.-Y., Lan, S.-W., Lin, H.-H., Tu, H.-F., Ho, C., Huang, H., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0400-2 · Cited by 17
Zahedi, A. M., Pirouzbakht, M., Zanganeh, S., & Afgar, A. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125902 · Cited by 16
Xu, T., Jin, F., Wu, K., Ye, Z., & Li, N. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5168 · Cited by 16
Chandler, K. B., Alamoud, K. A., Stahl, V. L., Nguyen, B.-C., Kartha, V. K., Bais, M. V., Nomoto, K., Owa, T., Monti, S., Kukuruzinska, M. A., et al. (2020) · Molecular Omics · doi:10.1039/d0mo00009d · Cited by 15
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer’s Disease
Barba, L., Halbgebauer, S., Paoletti, F. P., Bellomo, G., Abu‐Rumeileh, S., Steinacker, P., Massa, F., Parnetti, L., & Otto, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136922 · Cited by 14
Moonmuang, S., Tantraworasin, A., Orrapin, S., Udomruk, S., Chewaskulyong, B., Pruksakorn, D., & Chaiyawat, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054827 · Cited by 13
Montesino, B., Steenackers, A., Lozano, J. M., Young, G. D., Hu, N., Sackstein, R., & Chandler, K. B. (2021) · Glycobiology · doi:10.1093/glycob/cwab131 · Cited by 12
Goode, E. A., Orozco‐Moreno, M., Hodgson, K., Nabilah, A., Murali, M., Peng, Z., Merx, J., Rossing, E., Pijnenborg, J. F. A., Boltje, T. J., et al. (2024) · Cancers · doi:10.3390/cancers16172953 · Cited by 11
Xiong, J., Zhou, Z., Jiang, Y., Li, Q., Geng, Z., Guo, J., Yan, C., & Zhang, J. (2024) · Oncogene · doi:10.1038/s41388-024-03180-4 · Cited by 11
Aberrant Protein Glycosylation in Brain Cancers, with Emphasis on Glioblastoma
Rosa-Fernandes, L., Oba‐Shinjo, S. M., Macedo-da-Silva, J., Marie, S. K. N., & Palmisano, G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-05460-0_4 · Cited by 12
Hu, Y., Zhu, T., Nong, S., Sun, Y., Li, Y., Pan, J., Ma, J., & Zhang, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093941 · Cited by 10
Izadi, S., Gumpelmair, S., Coelho, P., Duarte, H. O., Gomes, J., Leitner, J. M., Kunnummel, V., Mach, L., Reis, C. A., Steinberger, P., et al. (2023) · Plant Biotechnology Journal · doi:10.1111/pbi.14260 · Cited by 10
Garbar, C., Mascaux, C., Merrouche, Y., & Bensussan, A. (2018) · Cancer Management and Research · doi:10.2147/cmar.s162932 · Cited by 10
O’Neill, A., Zakaria, N., Egan, H., Treacy, O., Hogan, A. M., O'Dwyer, M. E., Hynes, S. O., & Ryan, A. E. (2025) · European Journal of Immunology · doi:10.1002/eji.70000 · Cited by 10
Emerging role of sialylation in cancer therapy resistance: Mechanisms and therapeutic implications
Farrell, R. E., Stelzer, K. A., Liu, G. J., & Skropeta, D. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101285 · Cited by 10
Qausain, S., Hemalatha, S., Jamal, S., Nasiruddin, M., & Khan, M. K. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811913-6.00003-5 · Cited by 14
Alvarez, M. R., Holmes, X. A., Oloumi, A., Grijaldo-Alvarez, S. J. B., Schindler, R. L., Zhou, Q., Yadlapati, A., Silsirivanit, A., & Lebrilla, C. B. (2025) · Chemical Science · doi:10.1039/d5sc00467e · Cited by 8
Irani, M. A., & Ejtehadi, M. R. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1841027 · Cited by 8
SHP2–EGFR States in Dephosphorylation Can Inform Selective SHP2 Inhibitors, Dampening RasGAP Action
Liu, Y., Jang, H., & Nussinov, R. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c00873 · Cited by 7
Self-citationMa, Y., Zhang, F., Li, J., Li, J., & Li, Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1436033 · Cited by 8
Liu, Y., Chen, G., Yuan, X., Chen, Y., Cui, Y., & Cao, K. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.108072 · Cited by 6
Self-citationThe multifaceted roles of ST3GAL family in cancer: Mechanistic insights and therapeutic implications
Guo, J., Jia, W., & Jia, S. (2025) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2025.06.001 · Cited by 5
The effects of immortalization on the N-glycome and proteome of CDK4-transformed lung cancer cells
Alvarez, M. R., Moreno, P. G., Grijaldo-Alvarez, S. J. B., Yadlapati, A., Zhou, Q., Narciso, M. P., Completo, G. C. J., Nacario, R. C., Rabajante, J. F., Heralde, F. M., et al. (2024) · Glycobiology · doi:10.1093/glycob/cwae030 · Cited by 5
Sialic acids: An Avenue to Target Cancer Progression, Metastasis, and Resistance to Therapy
Goni, M., Javaregowda, P. K., Chachadi, V. B., & Virupakshaiah, D. B. M. (2021) · Forum of Clinical Oncology · doi:10.2478/fco-2021-0006 · Cited by 5
Genomic-Glycosylation Aberrations in Tumor Initiation, Progression and Management
Ip, C. K. M., Yin, J., Ng, P. K., Lin, S., & Mills, G. B. (2016) · AIMS Medical Science · doi:10.3934/medsci.2016.4.386 · Cited by 5
Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function
Lam, D., Arroyo, B., Liberchuk, A. N., Das, J., Ash, L. J., Khan, K. M., Mondal, J., & Wolfe, A. L. (2026) · Cancers · doi:10.3390/cancers18030474 · Cited by 4
Metadata
- Authors
- Yen, H.-Y., Liu, Y.-C., Chen, N.-Y., Tsai, C.-F., Wang, Y.-T., Chen, Y.-J., Hsu, T.-L., Yang, P.-C., & Wong, C.-H.
- Affiliations
- Institute of Biochemical Sciences and
- Genomics Research Center,
- National Yang Ming University (TW)
- National Taiwan University (TW)
- Institute of Chemistry (CN)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-05-13
- Volume
- 112
- Issue
- 22
- Pages
- 6955-6960
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4460513
- OpenAlex
- W1554182554
- Cited by
- 119
- References
- 47
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 8 · 2023: 9 · 2022: 13 · 2021: 14 · 2020: 11 · 2019: 13 · 2018: 14 · 2017: 11 · 2016: 11
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Keywords
- EGFR phosphorylation, tyrosine kinase inhibitor resistance, gefitinib resistance, lung cancer, receptor dimerization, autophosphorylation, neuraminidase, sialyltransferase inhibitors, desialylation, EGF binding
- MeSH terms
- Gefitinib, Enzyme Inhibitors, Humans, Models, Molecular, Neuraminidase, Phosphorylation, Protein Binding, Protein-Tyrosine Kinases, Quinazolines, Dimerization, Mutation, Missense, Cell Line, Tumor, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.